title: Imatinib-induced cytogenetic remission in chronic eosinophilic leukaemia.
authors.forename: A
authors.initials: A
authors.lastname: Willson
authors.forename: P
authors.initials: P
authors.lastname: Cannell
authors.forename: D
authors.initials: D
authors.lastname: Joske
authors.forename: B
authors.initials: B
authors.lastname: Augustson
mesh_terms: D001549:Benzamides; D002908:Chronic Disease; D020732:Cytogenetic Analysis; D004802:Eosinophilia / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate